Phosphate Toxicity and Vascular Calcification in Chronic Kidney Disease: A Closer Look Utilizing Transmission

Ying Yang1,2, Ke Yang2,3, Yuxin Xiong1,2

  • 1Department of Endocrinology, the Affiliated Hospital of Yunnan University and the Second People's Hospital of Yunnan Province, Kunming, Yunnan, 650021, China.

Insights

Hyperphosphatemia in chronic kidney disease (CKD) and end-stage renal disease (ESRD) is linked to severe complications. This review explores phosphate toxicity, FGF-23/Klotho axis, and vascular calcification in CKD.

Area of Science:

  • Nephrology
  • Cardiovascular Science
  • Metabolic Disorders

Background:

  • Hyperphosphatemia is a significant complication in chronic kidney disease (CKD) and end-stage renal disease (ESRD), independently associated with vascular calcification, cardiovascular disease, bone-mineral disease, and mortality.
  • The fibroblast growth factor-23 (FGF-23)/Klotho axis is crucial for phosphate homeostasis, with diminished renal Klotho production contributing to elevated phosphate levels in CKD.
  • Associated complications include calciphylaxis, renal tubulointerstitial disease, renal osteodystrophy, and uremic cardiomyopathy.

Purpose of the Study:

  • To review the multifaceted roles of phosphate homeostasis and toxicity in CKD and ESRD.
  • To examine the contribution of the FGF-23/Klotho axis to hyperphosphatemia and its consequences.
  • To explore the ultrastructural remodeling of the thoracic aorta and its relation to vascular calcification, incorporating insights from animal models.

Main Methods:

  • Review of existing literature on hyperphosphatemia, FGF-23, Klotho, and vascular calcification in CKD/ESRD.
  • Incorporation of ultrastructural remodeling data of the thoracic aorta.
  • Utilization of data from nine-week-old male heterozygous (mRen2) 27 (Ren2) rat models and Zucker obese (fa/fa) rat models.

Main Results:

  • Hyperphosphatemia is a key driver of vascular calcification, cardiovascular disease, and mortality in CKD/ESRD.
  • Dysregulation of the FGF-23/Klotho axis contributes to phosphate retention and associated pathologies.
  • Animal models demonstrate aortic remodeling linked to vascular calcification and provide insights into nephrolith formation.

Conclusions:

  • Phosphate homeostasis, toxicity, and the FGF-23/Klotho axis are central to understanding CKD/ESRD progression and complications.
  • Vascular calcification, driven by hyperphosphatemia, involves complex cellular and molecular mechanisms including oxidative stress and inflammation.
  • Further research into these pathways is essential for developing targeted therapies for CKD/ESRD patients.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
32
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
37
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
42
Roles of Electrolytes: Calcium and Phosphate01:27

Roles of Electrolytes: Calcium and Phosphate

Calcium and phosphate are essential electrolytes in the human body, with calcium being the most abundant mineral. Around 99% of the body's calcium is stored in the skeleton and teeth, forming a crystal lattice of mineral salts in combination with phosphates. Calcium plays crucial roles in various bodily functions such as blood clotting, neurotransmitter release, muscle tone maintenance, and nervous and muscle tissue excitability.
The calcium concentration in blood plasma is primarily...
330
Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
2.7K
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
25